Targeted Therapy for Neurofibromatosis Type-2 Mutated Vestibular Schwannomas
Neurofibromatosis-type 2 Mutated Vestibular Schwannomas is a rare genetic disorder that causes noncancerous tumors to grow on the auditory nerves, leading to hearing loss, tinnitus, and balance issues. In this MEDtalk, Shivani Chiranth from the Department for Cancer Treatment at DCCC Brain Tumor Center, Rigshospitalet in Denmark, presents the results of a systematic review that investigated the effectiveness and potential side effects of bevacizumab in treating patients with this condition.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in